Why the "Best" Alternative Depends on Why You're Leaving Noom Med
Patients leave Noom Med for different reasons, and the best replacement differs by reason. Before picking an alternative, identify which of these matches your situation.
💰 Leaving for cost / pricing clarity
Noom's "$69/month" is a base membership fee, not the medication — actual compounded semaglutide runs $79/month (microdose) to $279/month (full-dose), billed as $837 per 12-week cycle with no monthly option.
📷 Leaving because you don't use the coaching
You enrolled expecting to use Noom's CBT lessons and coaching but find you aren't opening the app. You're paying the base membership fee for a service you don't use.
💉 Leaving because you want tirzepatide
Noom Med does not offer compounded tirzepatide in any form — its GLP-1 program is semaglutide only. If tirzepatide is what you need, Noom Med cannot provide it at all.
🏥 Leaving for better clinical support
You want video consultations, insurance navigation for brand Wegovy, or more specialized clinical depth than Noom Med's async model provides.
What Noom Med Actually Costs — The True Monthly Total
Noom Med True Cost — June 2026
Best Alternatives Ranked by Use Case
Full Comparison Table
| Provider | Sema Effective | Coaching | Tirz Available | Pharmacy Named |
|---|---|---|---|---|
| Noom Med | ~$79–$279/mo | ✓ CBT | Not offered | No |
| ★ Luma Health | $197/mo flat | No | ✓ $297/mo flat | ✓ VialsRX TX#35264 |
| Ro Body | ~$294–$378/mo (w/ fee) | No | Not for new patients | Partial |
| Found | ~$129–$199/mo | ✓ Weight-loss | ✓ ~$199–$249/mo | No |
| Calibrate | ~$199/mo fee + ins. | ✓ Deep (1:1+labs) | ✓ (brand, ins.) | Retail pharmacy |
Frequently Asked Questions
For most patients leaving Noom Med, Luma Health is the best alternative: $197/month flat for semaglutide and $297/month flat for tirzepatide (which Noom Med doesn't offer at all), with VialsRX (TX #35264) publicly named as the compounding pharmacy and no separate membership fee. For patients who want video consultations or insurance navigation, Ro Body is worth considering, though verify current tirzepatide and compounded semaglutide availability directly, as both have changed in 2026.
No. Noom Med's GLP-1 program is built around semaglutide only — it does not offer compounded tirzepatide in any form as of 2026. Patients who want tirzepatide need to look elsewhere: Luma Health ($297/month flat), Found (~$199–$249/month), or another dedicated GLP-1 provider.
No — as long as you continue GLP-1 treatment at your current dose without a significant gap. STEP 4 data (Rubino et al., JAMA 2021) confirms that continued treatment maintains results while discontinuation leads to weight regain, regardless of which platform prescribes the medication. Start your new provider's intake with 2–3 weeks of Noom Med medication remaining so there's no gap.
Yes — Noom's CBT-based food psychology platform is the primary differentiator between Noom Med and medication-only alternatives. Clinical literature (Wadden et al., JAMA 2021) shows intensive behavioral therapy alongside semaglutide adds approximately 2 percentage points of weight loss over medication with standard clinical oversight. This benefit is only realized if you consistently engage with it — if you rarely open the Noom app, you were paying the membership fee without the clinical benefit it's designed to provide.
Start Luma Health's intake at start.mylumahealth.com while you still have 2 to 3 weeks of Noom Med medication remaining. Enter your current dose during intake — your Wasef Health, PC provider will prescribe at that dose, not restart titration. Wait for VialsRX shipping confirmation before canceling Noom Med. Cancel both the medication and any separate app subscription, and get written confirmation of both. See our full Noom Med exit checklist for the complete process.
Yes. If you want a coaching-included GLP-1 platform that also offers tirzepatide (which Noom Med doesn't), Found is the most direct alternative. Found's semaglutide starts at ~$129/month with dose-tier increases, and coaching is bundled into the subscription. Found's coaching is more practically oriented toward habits and accountability rather than the CBT-based food psychology Noom specifically focuses on.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed 33755728
- Wadden TA, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy. JAMA. 2021;325(14):1403–1413. PubMed 33755729
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- U.S. Food and Drug Administration. Human Drug Compounding — Section 503A. FDA.gov
- Noom Health. Noom Med Official Program and Pricing. noom.com
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov